Glucagon-like peptide-1 receptor agonists may cut the risk of obesity-related cancer in patients being treated for diabetes and obesity.

Adult-onset type 1 diabetes is associated with an increased risk for death and major adverse cardiovascular events.

Patients with gout living in rural vs urban areas face a significantly higher risk for MI-related hospitalization.

Individuals with Down syndrome are at increased risk of poor CV outcomes, including ischemic stroke and hemorrhagic stroke.

The increased rate of venous thromboembolism among patients with chronic kidney disease (CKD) warrants increased clinical attention.

A scientific statement has been published by the AHA regarding palliative care and advanced cardiovascular disease in adults.

Hormone reset diets have taken off on social media as the latest weight loss trend, but their scientific validity remains questionable.

Following HDP, Black and Hispanic patients, compared with White patients, are less likely to attend a postpartum visit.

For patients with immune-mediated inflammatory diseases, CVD mortality decreased from 1999 to 2020, but sex disparities ...

A US study found a significantly higher cost of care associated with cirrhosis vs with heart failure or chronic obstructive pulmonary disease.

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

Despite the approval of second-generation antiobesity medications, metabolic and bariatric surgery among US adolescents increased from 2021 to 2023.